| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |